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Abstract: COVID-19 is a severe acute respiratory syndrome (SARS) caused by a new coronavirus
(CoV), SARS-CoV-2, which is closely related to SARS-CoV that jumped the animal–human species bar-
rier and caused a disease outbreak in 2003. SARS-CoV-2 is a betacoronavirus that was first described
in 2019, unrelated to the commonly occurring feline coronavirus (FCoV) that is an alphacoronavirus
associated with feline infectious peritonitis (FIP). SARS-CoV-2 is highly contagious and has spread
globally within a few months, resulting in the current pandemic. Felids have been shown to be
susceptible to SARS-CoV-2 infection. Particularly in the Western world, many people live in very
close contact with their pet cats, and natural infections of cats in COVID-19-positive households have
been described in several countries. In this review, the European Advisory Board on Cat Diseases
(ABCD), a scientifically independent board of experts in feline medicine from 11 European Countries,
discusses the current status of SARS-CoV infections in cats. The review examines the host range of
SARS-CoV-2 and human-to-animal transmissions, including infections in domestic and non-domestic
felids, as well as mink-to-human/-cat transmission. It summarises current data on SARS-CoV-2
prevalence in domestic cats and the results of experimental infections of cats and provides expert
opinions on the clinical relevance and prevention of SARS-CoV-2 infection in cats.
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1. Introduction
The coronavirus (CoV) that causes coronavirus disease 2019 (COVID-19) was first
isolated in December 2019, in Wuhan City, Hubei province, China. The new virus is closely
related to the severe acute respiratory syndrome coronavirus (SARS-CoV) that caused a
disease outbreak in 2003 and has been named SARS coronavirus 2 (SARS-CoV-2). SARS-
CoV-2 is a member of the genus betacoronavirus, family Coronaviridae, order Nidovirales
(Table 1). It is a new strain that has not previously been identified in humans or animals.
SARS-CoV-2 did not emerge from any companion animal CoV; neither is it related to the
commonly occurring feline coronavirus (FCoV) associated with feline infectious peritonitis.
SARS-CoV-2 infection has spread to many countries worldwide, leading to the declaration
of a pandemic by the World Health Organisation on 11 March 2020 [1].
Table 1. Classification of coronaviruses (CoVs).







































2. Other Human Coronaviruses
To date, seven human coronaviruses (HCoVs) have been identified [2,3], as shown
in Table 1. All can cause respiratory illnesses in humans, ranging in severity from asymp-
tomatic infection or a mild, common cold to pneumonia and bronchiolitis.
In the last two decades, there have been two major human disease outbreaks associated
with coronaviruses: SARS [4] and Middle Eastern respiratory syndrome (MERS) [5]. Both
the SARS and MERS viruses evolved from viruses circulating in bats, the natural reservoir
host of many CoV [6,7]. Viruses with highly similar genetic sequences to SARS-CoV-2
have been isolated from bats, which indicates that, similar to previous CoV outbreaks, bats
are a potential source of the new CoV. It is currently not clear whether transmission of
SARS-CoV-2 occurred directly from bats to humans, or whether transmission occurred
indirectly, via an intermediate host.
Three of these seven human coronaviruses (agents of MERS, SARS, and COVID-19)
can cause severe illnesses and death, although some infections in some individuals can
be mild or asymptomatic. The other four common human coronaviruses typically cause
only mild respiratory illnesses in healthy human adults. However, they contribute to a
Viruses 2021, 13, 185 3 of 13
third of common cold infections and can cause life-threatening illnesses in immunocom-
promised people.
3. SARS-CoV Infections in Cats
SARS was first detected in 2002 and originated in a seafood market in Guangdong,
China [4,8,9]. The causative agent, SARS-CoV, spread from China around the world [10–12],
but the outbreak was contained after approximately nine months following strict infection
control measures [10]. The epidemic resulted in 8096 reported human cases and 774 deaths
in 27 countries [12].
SARS-CoV has been shown to infect a wide range of species under experimental condi-
tions, including masked palm civets [13], monkeys [14–20], mice [5,21], pigs, chickens [22],
guinea pigs [23,24], and Golden Syrian Hamsters [3,25]. The prevalence of SARS-CoV infec-
tion in masked palm civets (Paguma larvata) that were raised for human consumption was
high [26,27], and the animals developed neutralizing antibodies. Masked palm civets were
considered to be transient accidental hosts [28,29] and were also confirmed as occasional
direct sources of human infections [26,30,31].
Domestic cats can be infected experimentally with SARS-CoV and develop active
infection, shedding, and pulmonary changes very similar to those seen in fatal human
cases [32]. In an experimental study, SARS-CoV from a human patient who had died
from SARS was inoculated intratracheally in cats, and the virus could be isolated from
pharyngeal swabs taken on days two to eight post-infection and from nasal swabs taken
on days four and six post-infection, but SARS-CoV was not detected in rectal swabs;
however, no clinical signs were observed following experimental infection. Four cats were
euthanised and necropsied at four days post-infection, and SARS-CoV could be isolated
from the trachea and lungs, confirming infection of the lower respiratory tract. All of the
SARS-CoV-infected cats that were not euthanised developed neutralising antibodies by day
28 post-infection. Two uninfected cats that were housed together with SARS-CoV-infected
cats tested positive for SARS-CoV by RT-PCR, with viral loads gradually increasing from
two days post-infection onwards, peaking at days six to eight post-infection. Two in-
contact cats showed no clinical signs but developed antibodies by day 28 [32]. In another
study in which cats were experimentally infected intratracheally, pulmonary lesions were
also described [33]. Histologically, SARS-CoV was detected in cells expressing the ACE-2
receptor, and the cats had developed diffuse alveolar damage and many pathological
changes also seen in human SARS patients [33] with the difference that the cats developed
also tracheo-bronchoadenitis, which has not been reported in humans [33,34]. The data
from the two studies demonstrated that domestic cats are susceptible to experimental
infection with SARS-CoV, that the virus could be transmitted to other cats, and that clinical
signs and pathology were similar to those in humans [32,33].
Natural infection in field cats was also described during the first SARS outbreak
[27,28,31,35,36]. Domestic cats living in an apartment block in Hong Kong where 100 people
contracted SARS-CoV infection also tested RT-PCR-positive. However, final proof of direct
transmission from humans to cats was lacking [32,37,38]. Oropharyngeal and rectal swabs
were collected from cats from a multiple cat household and from two dogs in this apartment
block over 14 days, after their owners were diagnosed with SARS; eight cats and one of the
dogs tested RT-PCR-positive. Spontaneous infection of cats from another three multiple
pet households was demonstrated by RT-PCR of oropharyngeal and rectal swabs collected
over a 14-day period [37]. SARS-CoV was also isolated from the cats, with the sequenced
virus being indistinguishable from the human isolates [37]. Antibody testing using serum
neutralisation assays confirmed SARS-CoV infection in one RT-PCR-positive cat from one
household and in four of five cats (including three RT-PCR-positive cats) from another
household. The cats were isolated and kept in household groups in single cages and in
separate rooms while in isolation. There was limited evidence of spread in the isolation
cages (cats in close direct contact with these cats remained uninfected) [32,37,38].
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4. Host Range of SARS-CoV-2
The host range of a virus depends on several factors. The first step of viral infection
occurs when the virus particle binds to a susceptible host cell via specific interactions
between the receptor binding site on a viral protein and the virus receptor molecules on
the host cell, a key determinant of the host range and tissue tropism of a virus.
Both SARS-CoV and SARS-CoV-2 utilise the angiotensin-converting enzyme 2 (ACE-2)
molecule, a single-pass type I membrane protein, as the virus receptor for infection. ACE-2
is highly expressed in the lungs, arteries, heart, kidney, and intestines; it is an important
protein involved in blood pressure regulation. In addition to ACE-2, neuropilin-1 facilitates
SARS-CoV-2 cell entry and provides a possible pathway into the central nervous system.
The viral receptor binding site lies in a domain on the spike protein (S), a glycoprotein
that protrudes from the surface of the virus. The S protein and the viral receptor binding
site have been well studied for SARS-CoV, and recently extensive sequence analysis studies
and functional tests have been performed with SARS-CoV-2. The sequence of human
SARS-CoV-2 is similar to that of CoVs circulating in bats [39] that gave rise to SARS in 2002.
Related viruses have been found in Malayan pangolins [40,41], indicating these imported
animals might be intermediate hosts, although this has yet to be proven.
Three short regions of the ACE-2 molecule (3 to 11 amino acids long) have been
identified that are involved in virus binding, and a comparative analysis of the sequences
from different mammals, including humans, apes, macaques, horse, swine, goat, sheep,
bovine, cat, dog, rat, mouse, ferret, bat, and civet, revealed some differences [42]. The
sequences were identical for all apes, monkeys, and humans, but differences were found in
residues that are considered important for virus binding in other species. For cats and dogs,
one residue in ACE-2 that is critical for virus binding was different and, most interestingly,
the bat and civet sequences contained two critical residues that differed from the human
sequence. Although differences in the ACE-2 sequences from different animals have been
identified, the impact of these single amino acid changes on receptor binding and the
susceptibility of other species to infection is not yet known. However, the high overall
sequence identity could explain the relatively broad host range of SARS coronaviruses.
5. Evidence of Human-to-Cat Transmission of SARS-CoV-2
At the time of writing (30 December 2020), there have been numerous sporadic reports
of domestic animals from COVID-19 households that tested positive for SARS-CoV-2
and were presumed to be infected from their owners. Cats infected with SARS-CoV-2
have been identified in Belgium [43], Hong Kong [44], US [45], France [46], Spain [47,48],
Germany [49], UK [50], Italy [51], and Switzerland [52], and these cases, as well as cases
from Russia, Denmark, Sweden, Chile, Japan, Brazil, and Argentina have been reported to
OIE and appear on a list that is regularly updated by OIE [53].
The first cat that tested positive in Hong Kong was a domestic short-haired cat that
was quarantined when the owner was confirmed with COVID-19. Swabs collected from
the oral and nasal cavities and the rectum tested positive for SARS-CoV-2 RNA. The cat
did not show any signs of disease.
The first reported case in Europe was a cat living in Belgium with its owner, who was
self-isolating after testing positive for SARS-CoV-2, that developed clinical signs one week
after the owner’s return from Italy. The cat’s clinical signs (anorexia, diarrhoea, vomiting,
cough, and shallow breathing) were compatible with a CoV infection (respiratory and/or
digestive), and the cat tested positive for the SARS-CoV-2 RNA in successive samples
of faeces and vomitus. Positive RT-PCR results were confirmed by sequencing. Nine
days after the onset of clinical signs, the cat’s condition improved [43]. The test results
were consistent with a high number of viral RNA genomic copies (D. Desmecht, personal
communication), indicative of infection following human-to-cat transmission.
The first two cases of feline SARS-CoV-2 infection in the United States were confirmed
in New York by the CDC and the U.S. Department of Agriculture (USDA). The cats
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originated from separate households and were epidemiologically linked to suspected or
confirmed human COVID-19 cases in their respective households [54].
In addition to human-to-cat transmission, there have been reports of suspected human-
to-mink transmission in farmed mink in the Netherlands [55–57], Denmark, Italy, Spain,
USA, Sweden, Greece, France, Poland, and Lithuania [58]. It was reported that COVID-19
symptoms were present in humans working on the Dutch farms before clinical signs were
observed in mink, and infection was confirmed in one hospitalised person [59]. It is thought
that the widespread infection amongst the mink followed the introduction of the virus by
humans and subsequent transmission between the mink.
6. Evidence of Mink-to-Cat and Mink-to-Human Transmission
At the first mink farm found to be infected with SARS-CoV-2, antibodies against the
virus were detected in three of eleven farm cats, but no virus was isolated [55]. Later,
farm cats living on all four infected farms were sampled, and seven of 24 cats tested
antibody-positive; one cat tested positive for SARS-CoV-2 RNA.
The first two cases of mink-to-human transmission were reported from the Nether-
lands on two different mink farms. These findings were based on phylogenetic analysis of
sequences of the viruses in the infected mink and humans [59,60] and are consistent with
possible exposure of farm workers to virus in the environment that had been excreted by
the infected mink. Subsequently, it was decided to cull all mink in the affected farms [56,61].
Denmark reported 214 human COVID-19 cases infected with SARS-CoV-2 virus variants
related to mink, as well as infected mink at more than 200 mink farms [62]. The SARS-CoV-
2 variants that were detected contained three amino acid substitutions and one deletion
in the spike (S) protein. Since the S protein contains the receptor-binding domain and is a
major target for the immune response, the emergence of these variants has raised concerns
that such mutations could, in theory, influence the transmissibility and antigenicity of the
virus, and further investigations and studies are ongoing.
7. Prevalence of SARS-CoV-2 Infection in Domestic Animals
In Hong Kong, cats and dogs from households with infected people have been quaran-
tined by the Hong Kong Agriculture, Fisheries and Conservation Department (AFCD) [63].
The AFCD conducted tests on these cats and dogs from households with confirmed human
COVID-19 cases or persons in close contact with confirmed patients. One of 17 cats [64]
and two of 15 dogs [65] from confirmed COVID-19 households that had been placed in
quarantine in Hong Kong have tested RT-PCR-positive for SARS-CoV-2 RNA; antibodies
were also detected in both of the dogs [66], and the viral sequences from the dogs were
identical to those in the respective human contacts. More recently, Barrs et al. [44] reported
the results of testing 50 quarantined cats from COVID-19 households or close contacts
for SARS-CoV-2 RNA in respiratory and faecal swabs; six healthy cats tested positive,
suggesting human-to-feline transmission, and viral genomes sequenced from one cat and
its owner were identical.
Zhang et al. [67] reported that cats become infected with SARS-CoV-2 following nat-
ural exposure to infected people, with 15 of 102 (14.7%) cat sera collected following the
outbreak in Wuhan testing positive for antibodies that recognised the receptor binding
domain of SARS-CoV-2 by ELISA, eleven of which (10.8%) also tested positive for neu-
tralising antibodies. The results of this study imply that cat populations could become
infected in any region affected by the COVID-19 pandemic. The authors noted that sera
from three cats known to be owned by COVID-19 patients and, therefore, presumed to
have close contact, demonstrated higher neutralising antibody titres compared to sera
collected from either hospitalised or stray cats. Although the mechanism of transmission to
stray cats is not fully understood, stray cats could have become infected via SARS-CoV-2
contamination of their environment, from COVID-19 patients who fed the cats, or even as
a result of cat-to-cat transmission.
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A survey of cats and dogs from confirmed COVID-19 households in France reported a
high seroprevalence of SARS-CoV-2 antibodies, ranging from 21–53%, depending on the
criteria used to define a positive result [68]. In a longitudinal study of 76 cats and dogs
living in 39 COVID-19 households in Texas, US, eight of 17 cats and nine of 59 dogs tested
positive for SARS-CoV-2 RNA or neutralising antibodies [69]. Virus was isolated from one
out of three RT-PCR positive cats [69].
Other epidemiological studies have been conducted that included samples collected
from animals presenting for routine veterinary visits, where there was no known exposure
to people infected with SARS-CoV-2. A study of 919 companion animals in Northern
Italy that were sampled at a time of frequent human infection reported that 3.3% of dogs
and 5.8% of cats displayed titres of neutralising antibodies [70]. In this study, 69 samples
for serology originated from dogs (47) and cats (22) from a known COVID-19 affected
household and 12.8% (6/47) of these dogs and 4.5% (1/22) of these cats tested positive for
SARS-CoV-2-neutralizing antibodies; in addition, the seroprevalence found in dogs from a
known COVID-19 positive household was significantly higher than dogs from COVID-19
negative households (1.5%; 2/133) [70]. Along these lines, a German study of 920 serum
samples (which had been collected from domestic cats between April and September 2020
for haematological testing) demonstrated that only 0.69% (6/920) of samples contained
antibodies against SARS-CoV-2; two of the positive sera had neutralising antibodies [71],
suggesting that human-to-cat transmission might be relatively infrequent. Furthermore, a
study conducted in a veterinary community of 20 students, two of whom tested positive for
COVID-19 and eleven of the remaining 18 displayed symptoms of COVID-19, demonstrated
that none of the nine cats and none of the twelve dogs living in the community tested
positive by RT-PCR and none of the cats or dogs developed antibodies [72], which confirms
that human-to-domestic animal transmission is variable and suggests that transmission is
likely minimised where good hygiene is practised.
8. Evidence of Human-to-Non-Domestic Cat Transmission of SARS-CoV-2
SARS-CoV-2 infection of a non-domestic cat was first reported by the OIE on 4 April
2020 [73]. Nasal and oropharyngeal swabs and tracheal wash samples collected from
a 4-year-old female Malayan tiger (Panthera tigris jacksoni) with respiratory signs tested
positive for SARS-CoV-2 RNA. The tiger was kept in the Wildlife Conservation Society’s
(WCS) Bronx Zoo, where two Malayan tigers, two Amur tigers (Pantheratigris altaica), and
three African lions (Panthera leo) had developed respiratory signs over the course of a week
and showed clinical improvement following supportive treatment. On 15 April 2020, one
of the three lions was confirmed positive for SARS-CoV-2 [74]. As there had been no new
animal introductions for several years, it was presumed that SARS-CoV-2 was transmitted
to the tiger from a SARS-CoV-2-infected keeper who was either asymptomatic or pre-
symptomatic at the time of exposure. Subsequently, all of the tigers and lions in the group
tested positive when faecal samples were examined [75]. In addition, two Malayan tigers
in a zoo in Tennessee were tested for SARS-CoV-2 infection when the animals displayed
mild coughing, lethargy, and decreased appetite; one of the tigers tested positive [76].
9. Experimental Infection of Cats with SARS-CoV-2
It has been shown that cats, ferrets, and Golden Syrian hamsters can be infected
experimentally with SARS-CoV-2 [77–79]. Shi et al. [77] demonstrated that cats, ferrets,
and (to a lesser extent) dogs were susceptible to infection, but not pigs, chickens, or ducks.
When 8-month-old domestic cats were infected intranasally with 105 PFU of SARS-CoV-2
isolated from a human patient, viral RNA was detected in the upper respiratory tract, small
intestine, and faeces; infectious virus was found only in the upper respiratory tract, but
not from the tissues tested. When the same high dose of the virus was used to infect 10-to-
14-week-old kittens, viral RNA and infectious virus was detected in the upper respiratory
tract, lung, small intestine, and nasal washes, and histopathological changes were observed
in the lungs, suggesting that SARS-CoV-2 replicates more efficiently in younger cats. One of
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three 10-to-14-week-old kittens died on day three after virus exposure. Three infected 10-to-
14-week-old kittens and three infected 8-month-old domestic cats were housed individually
in cages adjacent to uninfected cats. Subsequently, two animals that were in cages adjacent
to experimentally infected cats became infected and developed antibodies; the exposed
cats that became infected were one 10-to-14-week-old kitten and one 8-month-old domestic
cat. However, as the exposed cats were in cages adjacent to the infected cats within an
isolator, it was not clear whether the mode of transmission was via respiratory droplets or
faeces, as the exposed cats might have also been exposed to the virus in the faeces of the
infected cats.
In another experimental study, three cats were inoculated with SARS-CoV-2 on day 0
and then cohoused, in pairs, with uninfected cats starting one day after inoculation [80].
The inoculated cats shed infectious virus in nasal swabs from day one to three, until day
six, and the in-contact cats started shedding virus from day three to day five. No virus was
detected in rectal swabs, and none of the cats displayed clinical signs, although all cats
developed antibodies confirming infection.
These experimental studies showed that cats are susceptible to SARS-CoV-2 infec-
tion [81]; however, the findings suggested that cats are unlikely to develop clinical disease
under these experimental conditions. In addition, these studies demonstrated that cats
develop a robust neutralising antibody response that prevents cats from being re-infected
following a second viral challenge. Further studies will be required to determine how
easily SARS-CoV-2 can be transmitted between cats. At present, no transmission event
from cats to humans has been reported.
10. Stability of Coronaviruses
CoV are enveloped viruses, and once the envelope is damaged or destroyed, the virus
is no longer infectious, which is why handwashing for at least 20 s (the WHO recommends
even 40 s [82]) with soap and water can prevent transmission of SARS-CoV-2. However,
CoV appear to be more stable in dry conditions compared to many other enveloped viruses,
remaining infectious for longer periods of time on surfaces. In addition, extraneous proteins
in blood or faeces can protect viruses from inactivation, prolonging viral infectivity [83].
The stability of coronaviruses is variable on surfaces, with the SARS-CoV, a beta-
coronavirus, being slightly more stable than the alphacoronavirus human coronavirus
HCoV-229E [84]. A recent study compared the stability of SARS-CoV and SARS-CoV-2
in aerosols and on surfaces and found virtually identical results [85], with both viruses
remaining infectious on dry surfaces for up to 72 h.
The nature of the surfaces, however, is crucial, and SARS-CoV-2 remains infectious for
longer on plastic and stainless-steel compared to cardboard or copper surfaces (24–72 h
versus 8–24 h, respectively) [85]. For SARS-, MERS-, and other human CoV, persistence was
tested on different types of inanimate surfaces (summarized in [86]): at room temperature,
persistence of several days was documented on metal, wood, paper, glass, and plastic with
a maximum of nine days on plastic in one study [84]. SARS-CoV and SARS-CoV-2 remained
viable and infectious in aerosols for hours and on different surfaces for days; these results
indicate that aerosol as well as fomite transmission of these viruses can be expected [85].
As with all other known enveloped viruses, CoV are highly susceptible to common
chemical disinfectants and are readily inactivated by, e.g., alcohols, household bleach,
benzalkonium, aldehydes, and others [86,87]. Differences have been observed between
cat litters concerning inactivation of the alphacoronavirus, FCoV. One study revealed that
some cat litters, particularly those based on bentonite, can bind and might inactivate CoV
shed in faeces and could help to reduce the FCoV load within infected households [88].
It is possible that cats could act as fomites when living in households with COVID-19
owners, although no studies have been published documenting the survival of SARS-CoV-2
on fur. Cats themselves should not be disinfected under any circumstances, as toxicity
and burns can result from the inappropriate use of disinfectants that could be ingested
during self-grooming.
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11. Diagnosis
At present, it is recommended that cats should be tested for SARS-CoV-2 infection
only following consultation with the appropriate public health authority, since recommen-
dations are different between countries. Testing is available in veterinary laboratories in
several European countries, using RT-PCR to detect viral RNA in swabs and ELISA to
detect antibodies in serum or plasma as well as virus neutralising antibody tests. Particu-
larly, antibody testing using ELISA should also undergo further evaluation to determine
specificity, sensitivity, and potential cross-reactivity for feline samples. Virus isolation
from swabs is restricted to specialist laboratories with containment level 3 facilities, as the
isolation of SARS-CoV-2 poses a risk to laboratory staff.
12. Conclusions
Given the potential for infected owners to transmit the virus to their pets, and the
possibility that cats could act as fomites, close contact with cats (and dogs) should be
avoided in households where people are infected with SARS-CoV-2 or have symptoms of
COVID-19. A One Health approach should be fostered, with Public Health and Veterinary
Services sharing information and investigating situations where a person who is infected
with SARS-CoV-2 reports being in contact with companion or other animals. If an owner
with COVID-19 must continue to care for their pet while ill, they should maintain basic
hygiene measures. Such measures include handling animals only when wearing a mask,
washing their hands with soap and water for at least 20 s before and after being near or
handling their animals, their food, or their supplies, as well as avoiding kissing their pets
or sharing food, towels, or the bed with them.
ABCD emphasises that at the time of writing, no transmission event from cats to
humans has been reported, although it is recognised that (for ethical reasons and limitations
on study design) it is unlikely that direct evidence of cat-to-human transmission could
be obtained [89]. In light of recent reports of SARS-CoV-2 infections in some cats living
in households with SARS-CoV-2-infected people, as well as the non-domestic cats that
were presumed to be infected by their zookeepers, it is recommended that cats from SARS-
CoV-2-infected households are kept indoors, until there is a better understanding of how
efficiently the virus is transmitted from humans to cats, whether cats can transmit virus
to other cats under natural conditions, and whether the virus could be transmitted from
cats to humans. Any cat from a COVID-19 household should not be taken into another
household. The American Veterinary Medical Association (AVMA) has developed detailed
protocols that could be implemented to protect staff when they are exposed to high-risk
situations, such as when entering an infected person’s home or coming into proximity with
a sick person. AVMA recommends that procedures should be consistent with the most
up-to-date guidance from the relevant public health authorities (AVMA, 2020).
This guideline will continue to be updated regularly on the ABCD homepage (www.
abcdcatsvets.org) as new data become available. In addition, ABCD has given answers
to common questions (see Appendix A); these are also available on the ABCD homepage.
Pet owners should always maintain good hygiene practices and under no circumstances
should cats be abandoned.
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Appendix A
Common questions on COVID-19 and cats
Note: These recommendations are based on the ABCD guidelines on SARS-CoV-2
(as of 30 December 2020) and will be updated regularly on the ABCD homepage (www.
abcdcatsvets.org).
What is the risk of a SARS-CoV-2-positive person infecting his or her cat?
To date, only few cats have been identified as infected following contact with SARS-
CoV-2-positive people. To reduce the risk of infection, close contact with pet cats should be
avoided in households where people are infected with SARS-CoV-2 or have symptoms of
COVID-19. However, cats should not be rehomed or relinquished.
What is the risk of a SARS-CoV-2 positive cat infecting his or her owner?
At the time of writing, no transmission event from cats to humans has been reported.
More than 80 million human COVID-19 cases have been reported worldwide and human-
to-human transmission is the main route of infection.
What are the clinical signs linked to SARS-CoV-2 infection in cats?
Following experimental infection, infectious virus was found in the upper respiratory
tract, so respiratory signs might develop, or infection could be subclinical. Kittens were
more susceptible following experimental infection compared to young adult cats, and
infectious virus was isolated from the intestines of experimentally infected kittens, but
not from young adult cats. The clinical signs that might be seen include respiratory signs,
enteric signs, or infections might be subclinical in some animals.
What should (self-isolating) SARS-CoV-2-positive people do if they have a cat?
Contacts between COVID-19 patients and their pets should be limited to a minimum.
However, cats in such households should remain in their home. It is preferable that they
are looked after by another asymptomatic member of the household.
What should be done with the cat if the owner needs to go to hospital?
If the patient lives alone or needs to be hospitalised, the cat should remain at home
and be cared for by friends or family of the patient, observing strict hygiene measures upon
entering/leaving the home. It is not recommended to rehome, isolate, or even euthanise
cats in these circumstances.
Can cats carry the virus on their fur and should they be disinfected?
Although it has not been proven, it is possible that fomite transmission could occur
via pets. Cats themselves should not be disinfected, only inanimate materials. However,
strict hygiene should be observed by the owners (washing hands after contact with cats)
and close physical contact with cats (e.g., licking face, sharing food, or towels) should
be avoided.
Should vets be testing such cats routinely?
The testing of cats for SARS-CoV-2 infection is not recommended; tests and reagents
must be prioritised for human testing.
What measures should cat owners take in COVID-19 affected areas?
There is a risk of cats contracting SARS-CoV-2 from their owner, but the risk is
minimised if standard hygiene measures are observed: avoid too close contact (e.g., licking
face, sharing food, or towels), washing their hands with soap and water for at least 20 s
(the WHO recommends even 40 s) before and after being near or handling their animals,
and regularly cleaning the litter box. This will minimise the risk of any zoonotic diseases.
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